A Phase 1, Single-Blind, Randomized, Placebo Controlled, Parallel-Group, Multiple-Dose-Escalation Study to Investigate Safety, Tolerability, and Pharmacokinetics of Emodepside (BAY 44-4400) After Oral Dosing in Healthy Male Subjects
收藏DataCite Commons2025-11-17 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00011756/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The study evaluates safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of emodepside, after administration as a Liquid Service Formulation (LSF), over 10 days, in healthy male caucasian subjects.
提供机构：
Vivli
创建时间：
2025-09-10
